Alemtuzumab Intravenous and Medroxyprogesterone
Determining the interaction of Alemtuzumab Intravenous and Medroxyprogesterone and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: medroxyprogesterone
Brand name: Provera, Depo-Provera, Depo-subQ provera 104, Depo-Provera Contraceptive
Synonyms: MedroxyPROGESTERone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab Intravenous-Medroxyprogesterone Acetate
- Alemtuzumab Intravenous-Medroxyprogesterone injection
- Alemtuzumab Intravenous-Medroxyprogesterone Injection (400 mg/mL)
- Alemtuzumab Intravenous-Medroxyprogesterone Injection (Intramuscular)
- Alemtuzumab Intravenous-Medroxyprogesterone Injection (Subcutaneous)
- Alemtuzumab Intravenous-Medroxyprogesterone Injection ER
- Medroxyprogesterone-Alenaze-D
- Medroxyprogesterone-Alendronate
- Medroxyprogesterone-Alendronate and cholecalciferol
- Medroxyprogesterone-Alendronate Effervescent Tablets
- Medroxyprogesterone-Alendronate Oral Solution
- Medroxyprogesterone-Alendronate Sodium